Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative

Acta Tropica

Volumn 95, Issue 3, 2005, Pages 172-182

  Sendagire, Hakim ^a   Kaddumukasa, Mark ^a   Ndagire, Dorothy ^a   Aguttu, Clare ^a   Nassejje, Maureen ^b   Pettersson, Madeleine ^b   Swedberg, Gote ^b   Kironde, Fred ^a  

^a MAKERERE UNIVERSITY   (Uganda)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Amodiaquine; Chloroquine; Falciparum; Fansidar; Resistance

Indexed keywords

AMODIAQUINE; CHLOROQUINE; FANSIDAR;

DISEASE CONTROL; DRUG RESISTANCE; HEALTH POLICY; MALARIA;

ARTICLE; CHILD; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENE LOCUS; GENE MUTATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; OUTCOMES RESEARCH; PLASMODIUM FALCIPARUM; SINGLE DRUG DOSE; TREATMENT FAILURE; UGANDA;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; CLINICAL TRIALS; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEMBRANE PROTEINS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE; UGANDA;

AFRICA; EAST AFRICA; EASTERN HEMISPHERE; SUB-SAHARAN AFRICA; UGANDA; WORLD;

PLASMODIUM FALCIPARUM;

EID: 23944485879     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2005.06.003     Document Type: Article

References (35)

1. A. Attaran, K.I. Barnes, C. Curtis, U. d'Alessandro, C.I. Fanello, M.R. Galinski, G. Kokwaro, S. Looareesuwan, M. Makanga, T.K. Mutabingwa, A. Talisuna, J.F. Trape, and W.M. Watkins WHO, the global fund, and medical malpractice in malaria treatment Lancet 363 2004 237 240
2. L.M. Barat, B. Himonga, S. Nkunika, M. Ettling, T.K. Ruebush, W. Kapelwa, and P.B. Bloland A systematic approach to the development of a rational malaria treatment policy in Zambia Trop. Med. Int. Health 3 1998 535 542
3. P.B. Bloland, and T.K. Ruebush Amodiaquine Lancet 348 1996 1659 1660
4. A.D. Brandling-Bennett, A.J. Oloo, W.M. Watkins, D.A. Boriga, D.M. Kariuki, and W.E. Collins Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance Trans. R. Soc. Trop. Med. Hyg. 82 1988 833 837
5. A. Cattamanchi, D. Kyabayinze, A. Hubbard, P.J. Rosenthal, and G. Dorsey Distinguishing recrudescence from reinfection in a longitudinal anti-malarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp Am. J. Trop. Med. Hyg. 68 2003 133 139
6. F. Checchi, P. Piola, C. Kosack, E. Ardizzoni, D. Klarkowski, E. Kwezi, G. Priotto, S. Balkan, N. Bakyaita, A. Brockman, and J.P. Guthmann Anti-malarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda Trop. Med. Int. Health 9 2004 445 450
7. G. Dorsey, M.R. Kamya, A. Singh, and P.J. Rosenthal Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda J. Infect. Dis. 183 2001 1417 1420
8. M.T. Duraisingh, J. Curtis, and D.C. Warhurst Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion Exp. Parasitol. 89 1998 1 8
9. B. Fenton, J.T. Clark, C.M. Khan, J.V. Robinson, D. Walliker, R. Ridley, J.G. Scaife, and J.S. McBride Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum Mol. Cell. Biol. 11 1991 963 974
10. A.F. Gasasira, G. Dorsey, B. Nzarubara, S.G. Staedke, A. Nassali, P.J. Rosenthal, and M.R. Kamya Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda Am. J. Trop. Med. Hyg. 68 2003 127 132
11. T.G. Geary, and J.B. Jensen Lack of cross-resistance to 4-aminoquinolines in chloroquine-resistant Plasmodium falciparum in vitro J. Parasitol. 69 1983 97 105
12. M.D. Hastings, S.J. Bates, E.A. Blackstone, S.M. Monks, T.K. Mutabingwa, and C.H. Sibley Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania Trans. R. Soc. Trop. Med. Hyg. 96 2002 674 676
13. M.R. Kamya, N.N. Bakyaita, A.O. Talisuna, W.M. Were, and S.G. Staedke Increasing anti-malarial drug resistance in Uganda and revision of the national drug policy Trop. Med. Int. Health 7 2002 1031 1041
14. M.R. Kamya, G. Dorsey, A. Gasasira, G. Ndeezi, J.N. Babirye, S.G. Staedke, and P.J. Rosenthal The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda Trans. R. Soc. Trop. Med. Hyg. 95 2001 50 55
15. D. Kyabayinze, A. Cattamanchi, M.R. Kamya, P.J. Rosenthal, and G. Dorsey Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria Am. J. Trop. Med. Hyg. 69 2003 pp. 247-252
16. J. Kyosiimire-Lugemwa, A.J. Nalunkuma-Kazibwe, G. Mujuzi, H. Mulindwa, A. Talisuna, and T.G. Egwang The Lys-76-Thr mutation in PfCRT and chloroquine resistance in Plasmodium falciparum isolates from Uganda Trans. R. Soc. Trop. Med. Hyg. 96 2002 91 95
17. McIntosh, H.M., 2001. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria. Cochrane Database Syst Rev: CD000386.
18. R. Ndyomugyenyi, and P. Magnussen In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, western Uganda Acta Trop. 66 1997 137 143
19. C.G. Nevill, and A. Gardner Pyrimethamine-sulfadoxine (Fansidar) resistance in a non-immune Kenyan - a case report East Afr. Med. J. 68 1991 149 151
20. O.C. Nwanyanwu, C. Ziba, P. Kazembe, L. Chitsulo, J.J. Wirima, N. Kumwenda, and S.C. Redd Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age Trop. Med. Int. Health 1 1996 231 235
21. S.A. Omar, I.S. Adagu, D.W. Gump, N.P. Ndaru, and D.C. Warhurst Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area Ann. Trop. Med. Parasitol. 95 2001 661 669
22. C.V. Plowe, J.F. Cortese, A. Djimde, O.C. Nwanyanwu, W.M. Watkins, P.A. Winstanley, J.G. Estrada-Franco, R.E. Mollinedo, J.C. Avila, J.L. Cespedes, D. Carter, and O.K. Doumbo Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance J. Infect. Dis. 176 1997 1590 1596
23. H. Sendagire, D. Kyabayinze, G. Swedberg, and F. Kironde Plasmodium falciparum: higher incidence of molecular resistance markers for sulfadoxine than for pyrimethamine in Kasangati, Uganda Trop. Med. Int. Health 10 2005 1 7
24. L.L. Smrkovski, R.L. Buck, A.K. Alcantara, C.S. Rodriguez, and C.V. Uylangco Studies of resistance to chloroquine, quinine, amodiaquine and mefloquine among Philippine strains of Plasmodium falciparum Trans. R. Soc. Trop. Med. Hyg. 79 1985 37 41
25. S.G. Staedke, M.R. Kamya, G. Dorsey, A. Gasasira, G. Ndeezi, E.D. Charlebois, and P.J. Rosenthal Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomized trial Lancet 358 2001 368 374
26. S.G. Staedke, H. Sendagire, S. Lamola, M.R. Kamya, G. Dorsey, and P.J. Rosenthal Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda Trop. Med. Int. Health 9 2004 624 629
27. A.O. Talisuna, P. Langi, T.K. Mutabingwa, W. Watkins, E. Van Marck, T.G. Egwang, and U. D'Alessandro Population-based validation of dihydrofolate reductase gene mutations for the prediction of sulfadoxine-pyrimethamine resistance in Uganda Trans. R. Soc. Trop. Med. Hyg. 97 2003 338 342
28. A.O. Talisuna, A. Nalunkuma-Kazibwe, N. Bakyaita, P. Langi, T.K. Mutabingwa, W.W. Watkins, E. Van Marck, U. D'Alessandro, and T.G. Egwang Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children Trop. Med. Int. Health. 9 2004 222 229
29. A.O. Talisuna, A. Nalunkuma-Kazibwe, P. Langi, T.K. Mutabingwa, W.W. Watkins, E. van Marck, T.G. Egwang, and U. D'Alessandro Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria Infect. Genet. Evol. 4 2004 321 327
30. Ugandan Ministry of Health 2000a. Background paper for the national consensus meeting to review anti-malaria policy in Uganda (June 2000).
31. Ugandan Ministry of Health 2000b. Report on the National consensus meeting for the review of the AMDP for Uganda, and implementation of the new antimalarial treatment drug policy: plan of action (November 2000).
32. F.H. Verhoeff, B.J. Brabin, P. Masache, B. Kachale, P. Kazembe, and H.J. Van der Kaay Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi Ann. Trop. Med. Parasitol. 91 1997 133 140
33. P. Wang, C.S. Lee, R. Bayoumi, A. Djimde, O. Doumbo, G. Swedberg, L.D. Dao, H. Mshinda, M. Tanner, W.M. Watkins, P.F. Sims, and J.E. Hyde Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins Mol. Biochem. Parasitol. 89 1997 161 177
34. WHO, 2001. Monitoring anti-malarial drug resistance, Report of a WHO consultation. Geneva, Switzerland, 3-5 December, 2001.
35. J. Zwetyenga, C. Rogier, A. Tall, D. Fontenille, G. Snounou, J.F. Trape, and O. Mercereau-Puijalon No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria Am. J. Trop. Med. Hyg. 59 1998 726 735